Headquartered in Los Angeles, CA Fiscal year ends December NASDAQ: CCAP crescentbdc.com
Crescent Capital BDC, Inc. (NASDAQ: CCAP) is a business development company that provides capital solutions to middle market companies. The company seeks to maximize total return through current income and capital appreciation by investing in senior secured first lien, unitranche, second lien, unsecured debt, and equity investments across a diversified portfolio. As of June 30, 2026, the company held investments in 192 portfolio companies with an aggregate fair value of $1.57 billion, with 98.4% of debt investments at floating rates. Crescent BDC is externally managed by Crescent Cap Advisors, LLC, a subsidiary of Crescent Capital Group, a global credit investment manager with approximately $50 billion of assets under management. Crescent Capital Group has over 30 years of experience in below investment grade credit and is part of SLC Management, the institutional alternatives and traditional asset management business of Sun Life. Updated
Five high-yield tickers have ex-dividend dates arriving in days, and buying even one session too late means the seller collects your payment instead. Before you place an order, check which of these…
Six stocks are paying yields as high as 23% right now, but behind those numbers sit eroding asset values, razor-thin coverage ratios, and balance sheets that leave almost no room for error…
BofA Securities has four top business development companies rated Buy, and they offer some of the highest dividends across Wall Street.
24/7 Wall Street Insights There are an estimated 29 million caregivers in the US who are caught in a spiral loop of work, caregiving, and escalating costs. Passive income is one of…
Dividend stocks are responsible for driving much of the returns in the S&P 500 Index over the years. We’ve uncovered a trio of dividend stocks that could be easy to overlook. Check…
Crescent Capital BDC, Inc. (NASDAQ: CCAP) is a business development company that provides capital solutions to middle market companies.
The Wall Street consensus 12-month price target for CCAP is $12.25.
